Overview
Dr. Cara McDermott is an Assistant Professor in Medicine, Division of Geriatrics, at Duke University School of Medicine. She has a K23 award from NIH's National Heart, Lung and Blood Institute on deprescribing fall-risk increasing drugs among multimorbid adults with chronic obstructive pulmonary disease. Her research focuses on identifying gaps in healthcare delivery and using implementation science to adapt and assess evidence-based interventions. Dr. McDermott works to optimize medication use, improve symptom management, and reduce unwanted healthcare use among older adults with multiple chronic conditions, with a particular interest in improving outcomes for patients with cancer, COPD, or dementia and their caregivers. She is particularly interested in improving shared decision making in this population and medication deprescribing for adults with serious illness. In recent projects, she investigated ways to improve end-of-life care from the perspective of bereaved caregivers and care delivery gaps leading to unwanted healthcare utilization at end of life for patients with multimorbidity. She completed a T32 postdoctoral fellowship with the Cambia Palliative Care Center of Excellence at the University of Washington and a K12 with the University of Washington’s Implementation Sciences Training Program.
Current Appointments & Affiliations
Recent Publications
Characterizing Intervention Components and Complexity of Nonpharmacologic Healthcare Interventions to Manage Distress Behaviors in Older Adults.
Journal Article J Appl Gerontol · April 28, 2025 Distress behaviors are common in residential care settings and contribute to staff burnout and poor quality of life for older adults. While nonpharmacologic interventions reduce distress behaviors, implementation in routine care remains challenging. Our st ... Full text Link to item CiteOpioids and benzodiazepines in oncology: Perspectives on coprescribing and mitigating risks.
Journal Article J Geriatr Oncol · March 2025 INTRODUCTION: Opioids and benzodiazepines are commonly prescribed for cancer symptoms. In combination, they can increase the risk of adverse events, particularly for older adults with multimorbidity, who represent most patients with cancer. We aimed to und ... Full text Link to item CiteLIVING WITH MULTIMORBIDITY AND FINANCIAL TOXICITY: A PATIENT- AND CLINICIAN-INFORMED FRAMEWORK
Conference Innovation in Aging · December 31, 2024 AbstractMost older adults in the US have multimorbidity (2+ serious illnesses). Living with multimorbidity impacts patient quality of life, specifically managing the symptoms of multiple diseases and accompa ... Full text CiteRecent Grants
Models of Post-Acute Care in Complex Older Adults with Fracture
ResearchCo Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2024 - 2030Duke/UNC ADAR Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Reducing Polypharmacy and Fall Risk for Multi-Morbid Adults with Chronic Obstructive Pulmonary Disease
ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2026View All Grants